Aleva is developing a neurostimulation platform based on the DBS (Deep Brain Stimulation) technique to improve the treatment of certain symptoms such as the tremors of Parkinson’s disease.

heads

André MERCANZINI

Alain JORDAN

Alain DRANSART

Peter BERGSMA

Investor

Michel DAHAN